Guarantor and Non-Guarantor Financial Statements (Details) - USD ($)		3 Months Ended								12 Months Ended
		Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jun. 01, 2016	May 15, 2016	Dec. 31, 2014	May 23, 2012
Condensed Financial Statements [Line Items]
Ownership interest by parent		100.00%								100.00%
Current assets:
Cash and cash equivalents		$ 51,100,000				$ 55,200,000				$ 51,100,000	$ 55,200,000	$ 72,500,000
Short-term investments		183,700,000				231,000,000				183,700,000	231,000,000
Receivables:
Trade, less allowance for doubtful receivables		165,000,000				137,700,000				165,000,000	137,700,000
Intercompany receivables		0				0				0	0
Other		15,500,000				11,900,000				15,500,000	11,900,000
Inventories		207,900,000				201,600,000				207,900,000	201,600,000
Prepaid expenses and other current assets		33,400,000				18,500,000				33,400,000	18,500,000
Total current assets		656,600,000				655,900,000				656,600,000	655,900,000
Investments in and advances to unconsolidated affiliates		0				0				0	0
Property, plant and equipment, net		571,400,000				530,900,000				571,400,000	530,900,000
Long-term intercompany receivables		0				0				0	0
Deferred tax assets — net		72,000,000				159,700,000				72,000,000	159,700,000
Intangible assets, net		25,000,000				26,400,000				25,000,000	26,400,000
Goodwill		18,800,000				37,200,000				18,800,000	37,200,000
Other assets		41,400,000				33,400,000				41,400,000	33,400,000
Total		1,385,200,000				1,443,500,000				1,385,200,000	1,443,500,000	1,246,900,000
Current liabilities:
Accounts payable		90,000,000				75,800,000				90,000,000	75,800,000
Intercompany payable		0				0				0	0
Accrued salaries, wages and related expenses		42,600,000				49,100,000				42,600,000	49,100,000
Other accrued liabilities		40,500,000				40,100,000				40,500,000	40,100,000
Total current liabilities		173,100,000				165,000,000				173,100,000	165,000,000
Net liabilities of Salaried VEBA		31,900,000				28,600,000				31,900,000	28,600,000
Deferred tax liabilities		4,300,000				3,300,000				4,300,000	3,300,000
Long-term intercompany payable		0				0				0	0
Long-term liabilities		60,000,000				73,200,000				60,000,000	73,200,000
Long-term debt		369,600,000				368,700,000				369,600,000	368,700,000
Total liabilities		638,900,000				638,800,000				638,900,000	638,800,000
Total stockholders’ equity		746,300,000				804,700,000				746,300,000	804,700,000				$ 1,015,900,000
Total		1,385,200,000				1,443,500,000				1,385,200,000	1,443,500,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales		353,100,000	$ 332,800,000	$ 356,300,000	$ 355,300,000	331,900,000	$ 320,600,000	$ 334,900,000	$ 343,200,000	1,397,500,000	1,330,600,000	1,391,900,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items		282,600,000	267,200,000	277,700,000	277,800,000	252,400,000	254,700,000	250,400,000	262,000,000	1,105,300,000	1,019,500,000	1,115,400,000
Lower of cost or market inventory write-down						0	0	0	4,900,000	0	4,900,000	2,600,000
Unrealized (gain) loss on derivative instruments		(5,400,000)	(10,800,000)	11,900,000	(15,100,000)	(1,800,000)	(2,000,000)	(10,900,000)	(4,000,000)	(19,400,000)	(18,700,000)	3,400,000
Depreciation and amortization										39,700,000	36,000,000	32,400,000
Selling, general, administrative, research and development										97,500,000	105,000,000	88,100,000
Net periodic postretirement benefit cost relating to Salaried VEBA										4,500,000	3,400,000	2,400,000
(Gain) loss on removal of Union VEBA net assets – Note 4										0	(100,000)	493,400,000
Total selling, administrative, research and development and general										102,000,000	108,300,000	583,900,000
Goodwill impairment										18,400,000	0	0
Other operating charges, net										800,000	2,800,000	100,000
Total costs and expenses										1,246,800,000	1,152,800,000	1,737,800,000
Operating (loss) income		40,000,000	39,800,000	11,400,000	59,500,000	45,300,000	29,800,000	57,900,000	44,800,000	150,700,000	177,800,000	(345,900,000)
Interest expense										(22,200,000)	(20,300,000)	(24,100,000)
Other (expense) income:
Other income, net										4,500,000	(10,300,000)	(1,800,000)
(Loss) income before income taxes										133,000,000	147,200,000	(371,800,000)
Income tax provision										(87,600,000)	(55,500,000)	135,200,000
Earnings in equity of subsidiaries										0	0	0
Net income (loss)		(15,200,000)	$ 19,900,000	$ 4,700,000	36,000,000	24,500,000	$ 14,900,000	$ 26,000,000	26,300,000	45,400,000	91,700,000	(236,600,000)
Comprehensive (loss) income										45,400,000	86,700,000	(172,200,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										141,500,000	165,600,000	159,700,000
Cash flows from investing activities:
Capital expenditures										(75,500,000)	(76,100,000)	(63,100,000)
Purchase of available for sale securities										(247,500,000)	(255,300,000)	(500,000)
Proceeds from disposition of available for sale securities										296,900,000	55,000,000	84,000,000
Proceeds from disposal of property, plant and equipment										600,000	0	0
Intercompany loans receivable										0	0
Net cash (used in) provided by investing activities	[1]									(25,500,000)	(276,400,000)	20,400,000
Repayment of principal and redemption premium of 8.25% Senior Notes										0	(206,000,000)	(30,000,000)
Issuance of 5.875% Senior Notes										0	375,000,000	0
Repayment of Convertible Notes										0	0	(175,000,000)
Proceeds from cash-settled call options related to settlement of Convertible Notes										0	0	94,900,000
Payment for conversion premium related to settlement of Convertible Notes										0	0	(94,900,000)
Cash paid for debt issuance costs										0	(6,800,000)	(600,000)
Proceeds from stock option exercises										0	1,200,000	0
Repayment of capital lease										400,000	0	0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest										0	0	1,300,000
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										(4,500,000)	(2,900,000)	(2,800,000)
Repurchase of common stock										(79,500,000)	(33,300,000)	(49,200,000)
Cash dividends and dividend equivalents paid										(35,000,000)	(32,400,000)	(28,100,000)
Cash dividends paid to Parent											0
Intercompany loans payable										0	0	0
Net cash (used in) provided by financing activities	[1]									(119,400,000)	94,800,000	(284,400,000)
Net decrease in cash, cash equivalents and restricted cash during the period										(3,400,000)	(16,000,000)	(104,300,000)
Cash, cash equivalents and restricted cash at beginning of period					67,700,000				83,700,000	67,700,000	83,700,000	188,000,000
Cash, cash equivalents and restricted cash at end of period		64,300,000				67,700,000				64,300,000	67,700,000	83,700,000
Consolidating Adjustments
Current assets:
Cash and cash equivalents		0				0				0	0
Short-term investments		0				0				0	0
Receivables:
Trade, less allowance for doubtful receivables		0				0				0	0
Intercompany receivables		(23,600,000)				(86,500,000)				(23,600,000)	(86,500,000)
Other		0				0				0	0
Inventories		0				(3,900,000)				0	(3,900,000)
Prepaid expenses and other current assets		0				(500,000)				0	(500,000)
Total current assets		(23,600,000)				(90,900,000)				(23,600,000)	(90,900,000)
Investments in and advances to unconsolidated affiliates		(1,145,900,000)				(1,052,500,000)				(1,145,900,000)	(1,052,500,000)
Property, plant and equipment, net		0				0				0	0
Long-term intercompany receivables		(12,400,000)				(85,100,000)				(12,400,000)	(85,100,000)
Deferred tax assets — net		4,700,000				4,800,000				4,700,000	4,800,000
Intangible assets, net		0				0				0	0
Goodwill		0				0				0	0
Other assets		0				0				0	0
Total		(1,177,200,000)				(1,223,700,000)				(1,177,200,000)	(1,223,700,000)
Current liabilities:
Accounts payable		0				0				0	0
Intercompany payable		(23,600,000)				(86,500,000)				(23,600,000)	(86,500,000)
Accrued salaries, wages and related expenses		0				0				0	0
Other accrued liabilities		(9,500,000)				(14,700,000)				(9,500,000)	(14,700,000)
Total current liabilities		(33,100,000)				(101,200,000)				(33,100,000)	(101,200,000)
Net liabilities of Salaried VEBA		0				0				0	0
Deferred tax liabilities		0				0				0	0
Long-term intercompany payable		(12,400,000)				(85,100,000)				(12,400,000)	(85,100,000)
Long-term liabilities		0				0				0	0
Long-term debt		0				0				0	0
Total liabilities		(45,500,000)				(186,300,000)				(45,500,000)	(186,300,000)
Total stockholders’ equity		(1,131,700,000)				(1,037,400,000)				(1,131,700,000)	(1,037,400,000)
Total		(1,177,200,000)				(1,223,700,000)				(1,177,200,000)	(1,223,700,000)
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										(83,500,000)	(74,400,000)	(93,000,000)
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										(81,300,000)	(71,100,000)	(88,600,000)
Lower of cost or market inventory write-down											0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										0	0	0
Selling, general, administrative, research and development										(2,200,000)	(2,600,000)	(2,000,000)
Net periodic postretirement benefit cost relating to Salaried VEBA										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 4											0	0
Total selling, administrative, research and development and general										(2,200,000)	(2,600,000)	(2,000,000)
Goodwill impairment										0
Other operating charges, net										0	0	0
Total costs and expenses										(83,500,000)	(73,700,000)	(90,600,000)
Operating (loss) income										0	(700,000)	(2,400,000)
Interest expense										200,000	100,000	300,000
Other (expense) income:
Other income, net										(200,000)	(100,000)	(300,000)
(Loss) income before income taxes										0	(700,000)	(2,400,000)
Income tax provision										9,500,000	14,100,000	11,400,000
Earnings in equity of subsidiaries										(74,900,000)	(130,300,000)	205,400,000
Net income (loss)										(65,400,000)	(116,900,000)	214,400,000
Comprehensive (loss) income										(65,400,000)	(111,900,000)	150,000,000
Cash flows from operating activities:
Net cash (used in) provided by operating activities										0	(200,000,000)	0
Cash flows from investing activities:
Capital expenditures										0	0	0
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Proceeds from disposal of property, plant and equipment										0
Intercompany loans receivable										(135,600,000)	56,900,000
Net cash (used in) provided by investing activities										(135,600,000)	56,900,000	0
Repayment of principal and redemption premium of 8.25% Senior Notes											0	0
Issuance of 5.875% Senior Notes											0
Repayment of Convertible Notes												0
Proceeds from cash-settled call options related to settlement of Convertible Notes												0
Payment for conversion premium related to settlement of Convertible Notes												0
Cash paid for debt issuance costs											0	0
Proceeds from stock option exercises											0
Repayment of capital lease										0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest												0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends and dividend equivalents paid										0	0	0
Cash dividends paid to Parent											200,000,000
Intercompany loans payable										135,600,000	(56,900,000)	0
Net cash (used in) provided by financing activities										135,600,000	143,100,000	0
Net decrease in cash, cash equivalents and restricted cash during the period										0	0	0
Cash, cash equivalents and restricted cash at beginning of period					0				0	0	0	0
Cash, cash equivalents and restricted cash at end of period		0				0				0	0	0
Parent Company [Member]
Current assets:
Cash and cash equivalents		0				0				0	0
Short-term investments		0				0				0	0
Receivables:
Trade, less allowance for doubtful receivables		0				0				0	0
Intercompany receivables		22,800,000				85,800,000				22,800,000	85,800,000
Other		0				0				0	0
Inventories		0				0				0	0
Prepaid expenses and other current assets		100,000				100,000				100,000	100,000
Total current assets		22,900,000				85,900,000				22,900,000	85,900,000
Investments in and advances to unconsolidated affiliates		1,097,700,000				1,012,400,000				1,097,700,000	1,012,400,000
Property, plant and equipment, net		0				0				0	0
Long-term intercompany receivables		0				80,200,000				0	80,200,000
Deferred tax assets — net		0				0				0	0
Intangible assets, net		0				0				0	0
Goodwill		0				0				0	0
Other assets		0				0				0	0
Total		1,120,600,000				1,178,500,000				1,120,600,000	1,178,500,000
Current liabilities:
Accounts payable		1,900,000				2,200,000				1,900,000	2,200,000
Intercompany payable		0				0				0	0
Accrued salaries, wages and related expenses		0				0				0	0
Other accrued liabilities		2,800,000				2,900,000				2,800,000	2,900,000
Total current liabilities		4,700,000				5,100,000				4,700,000	5,100,000
Net liabilities of Salaried VEBA		0				0				0	0
Deferred tax liabilities		0				0				0	0
Long-term intercompany payable		0				0				0	0
Long-term liabilities		0				0				0	0
Long-term debt		369,600,000				368,700,000				369,600,000	368,700,000
Total liabilities		374,300,000				373,800,000				374,300,000	373,800,000
Total stockholders’ equity		746,300,000				804,700,000				746,300,000	804,700,000
Total		1,120,600,000				1,178,500,000				1,120,600,000	1,178,500,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										0	0	0
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										0	0	0
Lower of cost or market inventory write-down											0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										0	0	0
Selling, general, administrative, research and development										4,500,000	4,200,000	4,300,000
Net periodic postretirement benefit cost relating to Salaried VEBA										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 4											0	0
Total selling, administrative, research and development and general										4,500,000	4,200,000	4,300,000
Goodwill impairment										0
Other operating charges, net										0	0	0
Total costs and expenses										4,500,000	4,200,000	4,300,000
Operating (loss) income										(4,500,000)	(4,200,000)	(4,300,000)
Interest expense										(20,700,000)	(21,600,000)	(23,500,000)
Other (expense) income:
Other income, net										0	(11,100,000)	(2,500,000)
(Loss) income before income taxes										(25,200,000)	(36,900,000)	(30,300,000)
Income tax provision										0	0	0
Earnings in equity of subsidiaries										70,600,000	128,600,000	(206,300,000)
Net income (loss)										45,400,000	91,700,000	(236,600,000)
Comprehensive (loss) income										45,400,000	86,700,000	(172,200,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										(24,200,000)	177,700,000	285,700,000
Cash flows from investing activities:
Capital expenditures										0	0	0
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Proceeds from disposal of property, plant and equipment										0
Intercompany loans receivable										143,200,000	(166,000,000)
Net cash (used in) provided by investing activities										143,200,000	(166,000,000)	0
Repayment of principal and redemption premium of 8.25% Senior Notes											(206,000,000)	(30,000,000)
Issuance of 5.875% Senior Notes											375,000,000
Repayment of Convertible Notes												(175,000,000)
Proceeds from cash-settled call options related to settlement of Convertible Notes												94,900,000
Payment for conversion premium related to settlement of Convertible Notes												(94,900,000)
Cash paid for debt issuance costs											(6,800,000)	(600,000)
Proceeds from stock option exercises											1,200,000
Repayment of capital lease										0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest												0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										(4,500,000)	(2,900,000)	(2,800,000)
Repurchase of common stock										(79,500,000)	(33,300,000)	(49,200,000)
Cash dividends and dividend equivalents paid										(35,000,000)	(32,400,000)	(28,100,000)
Cash dividends paid to Parent											0
Intercompany loans payable										0	(106,500,000)	0
Net cash (used in) provided by financing activities										(119,000,000)	(11,700,000)	(285,700,000)
Net decrease in cash, cash equivalents and restricted cash during the period										0	0	0
Cash, cash equivalents and restricted cash at beginning of period					0				0	0	0	0
Cash, cash equivalents and restricted cash at end of period		0				0				0	0	0
Guarantor Subsidiaries
Current assets:
Cash and cash equivalents		48,400,000				52,900,000				48,400,000	52,900,000
Short-term investments		183,700,000				231,000,000				183,700,000	231,000,000
Receivables:
Trade, less allowance for doubtful receivables		160,100,000				133,100,000				160,100,000	133,100,000
Intercompany receivables		100,000				100,000				100,000	100,000
Other		14,700,000				11,400,000				14,700,000	11,400,000
Inventories		198,700,000				197,500,000				198,700,000	197,500,000
Prepaid expenses and other current assets		32,900,000				18,000,000				32,900,000	18,000,000
Total current assets		638,600,000				644,000,000				638,600,000	644,000,000
Investments in and advances to unconsolidated affiliates		48,200,000				40,100,000				48,200,000	40,100,000
Property, plant and equipment, net		541,200,000				499,500,000				541,200,000	499,500,000
Long-term intercompany receivables		0				0				0	0
Deferred tax assets — net		67,300,000				154,900,000				67,300,000	154,900,000
Intangible assets, net		25,000,000				26,400,000				25,000,000	26,400,000
Goodwill		18,800,000				37,200,000				18,800,000	37,200,000
Other assets		41,400,000				33,400,000				41,400,000	33,400,000
Total		1,380,500,000				1,435,500,000				1,380,500,000	1,435,500,000
Current liabilities:
Accounts payable		81,400,000				68,900,000				81,400,000	68,900,000
Intercompany payable		23,500,000				86,400,000				23,500,000	86,400,000
Accrued salaries, wages and related expenses		41,000,000				47,200,000				41,000,000	47,200,000
Other accrued liabilities		46,200,000				52,600,000				46,200,000	52,600,000
Total current liabilities		192,100,000				255,100,000				192,100,000	255,100,000
Net liabilities of Salaried VEBA		31,900,000				28,600,000				31,900,000	28,600,000
Deferred tax liabilities		0				0				0	0
Long-term intercompany payable		12,400,000				85,100,000				12,400,000	85,100,000
Long-term liabilities		58,000,000				70,500,000				58,000,000	70,500,000
Long-term debt		0				0				0	0
Total liabilities		294,400,000				439,300,000				294,400,000	439,300,000
Total stockholders’ equity		1,086,100,000				996,200,000				1,086,100,000	996,200,000
Total		1,380,500,000				1,435,500,000				1,380,500,000	1,435,500,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										1,365,300,000	1,301,600,000	1,361,600,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										1,085,500,000	1,000,600,000	1,095,600,000
Lower of cost or market inventory write-down											4,900,000	2,600,000
Unrealized (gain) loss on derivative instruments										(19,400,000)	(18,700,000)	3,400,000
Depreciation and amortization										37,500,000	34,000,000	31,300,000
Selling, general, administrative, research and development										88,300,000	95,000,000	76,500,000
Net periodic postretirement benefit cost relating to Salaried VEBA										4,500,000	3,400,000	2,400,000
(Gain) loss on removal of Union VEBA net assets – Note 4											(100,000)	493,400,000
Total selling, administrative, research and development and general										92,800,000	98,300,000	572,300,000
Goodwill impairment										18,400,000
Other operating charges, net										800,000	2,800,000	100,000
Total costs and expenses										1,215,600,000	1,121,900,000	1,705,300,000
Operating (loss) income										149,700,000	179,700,000	(343,700,000)
Interest expense										(1,700,000)	1,200,000	(900,000)
Other (expense) income:
Other income, net										4,000,000	900,000	3,500,000
(Loss) income before income taxes										152,000,000	181,800,000	(341,100,000)
Income tax provision										(95,200,000)	(69,000,000)	122,500,000
Earnings in equity of subsidiaries										4,300,000	1,700,000	900,000
Net income (loss)										61,100,000	114,500,000	(217,700,000)
Comprehensive (loss) income										61,100,000	109,800,000	(153,500,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										156,900,000	178,700,000	(126,300,000)
Cash flows from investing activities:
Capital expenditures										(74,700,000)	(74,000,000)	(47,900,000)
Purchase of available for sale securities										(247,500,000)	(255,300,000)	(500,000)
Proceeds from disposition of available for sale securities										296,900,000	55,000,000	84,000,000
Proceeds from disposal of property, plant and equipment										600,000
Intercompany loans receivable										0	110,400,000
Net cash (used in) provided by investing activities										(24,700,000)	(163,900,000)	35,600,000
Repayment of principal and redemption premium of 8.25% Senior Notes											0	0
Issuance of 5.875% Senior Notes											0
Repayment of Convertible Notes												0
Proceeds from cash-settled call options related to settlement of Convertible Notes												0
Payment for conversion premium related to settlement of Convertible Notes												0
Cash paid for debt issuance costs											0	0
Proceeds from stock option exercises											0
Repayment of capital lease										400,000
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest												1,300,000
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends and dividend equivalents paid										0	0	0
Cash dividends paid to Parent											(200,000,000)
Intercompany loans payable										(135,600,000)	167,300,000	(12,800,000)
Net cash (used in) provided by financing activities										(136,000,000)	(32,700,000)	(11,500,000)
Net decrease in cash, cash equivalents and restricted cash during the period										(3,800,000)	(17,900,000)	(102,200,000)
Cash, cash equivalents and restricted cash at beginning of period					65,100,000				83,000,000	65,100,000	83,000,000	185,200,000
Cash, cash equivalents and restricted cash at end of period		61,300,000				65,100,000				61,300,000	65,100,000	83,000,000
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents		2,700,000				2,300,000				2,700,000	2,300,000
Short-term investments		0				0				0	0
Receivables:
Trade, less allowance for doubtful receivables		4,900,000				4,600,000				4,900,000	4,600,000
Intercompany receivables		700,000				600,000				700,000	600,000
Other		800,000				500,000				800,000	500,000
Inventories		9,200,000				8,000,000				9,200,000	8,000,000
Prepaid expenses and other current assets		400,000				900,000				400,000	900,000
Total current assets		18,700,000				16,900,000				18,700,000	16,900,000
Investments in and advances to unconsolidated affiliates		0				0				0	0
Property, plant and equipment, net		30,200,000				31,400,000				30,200,000	31,400,000
Long-term intercompany receivables		12,400,000				4,900,000				12,400,000	4,900,000
Deferred tax assets — net		0				0				0	0
Intangible assets, net		0				0				0	0
Goodwill		0				0				0	0
Other assets		0				0				0	0
Total		61,300,000				53,200,000				61,300,000	53,200,000
Current liabilities:
Accounts payable		6,700,000				4,700,000				6,700,000	4,700,000
Intercompany payable		100,000				100,000				100,000	100,000
Accrued salaries, wages and related expenses		1,600,000				1,900,000				1,600,000	1,900,000
Other accrued liabilities		1,000,000				(700,000)				1,000,000	(700,000)
Total current liabilities		9,400,000				6,000,000				9,400,000	6,000,000
Net liabilities of Salaried VEBA		0				0				0	0
Deferred tax liabilities		4,300,000				3,300,000				4,300,000	3,300,000
Long-term intercompany payable		0				0				0	0
Long-term liabilities		2,000,000				2,700,000				2,000,000	2,700,000
Long-term debt		0				0				0	0
Total liabilities		15,700,000				12,000,000				15,700,000	12,000,000
Total stockholders’ equity		45,600,000				41,200,000				45,600,000	41,200,000
Total		61,300,000				53,200,000				61,300,000	53,200,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										115,700,000	103,400,000	123,300,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										101,100,000	90,000,000	108,400,000
Lower of cost or market inventory write-down											0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										2,200,000	2,000,000	1,100,000
Selling, general, administrative, research and development										6,900,000	8,400,000	9,300,000
Net periodic postretirement benefit cost relating to Salaried VEBA										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 4											0	0
Total selling, administrative, research and development and general										6,900,000	8,400,000	9,300,000
Goodwill impairment										0
Other operating charges, net										0	0	0
Total costs and expenses										110,200,000	100,400,000	118,800,000
Operating (loss) income										5,500,000	3,000,000	4,500,000
Interest expense										0	0	0
Other (expense) income:
Other income, net										700,000	0	(2,500,000)
(Loss) income before income taxes										6,200,000	3,000,000	2,000,000
Income tax provision										(1,900,000)	(600,000)	1,300,000
Earnings in equity of subsidiaries										0	0	0
Net income (loss)										4,300,000	2,400,000	3,300,000
Comprehensive (loss) income										4,300,000	2,100,000	3,500,000
Cash flows from operating activities:
Net cash (used in) provided by operating activities										8,800,000	9,200,000	300,000
Cash flows from investing activities:
Capital expenditures										(800,000)	(2,100,000)	(15,200,000)
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Proceeds from disposal of property, plant and equipment										0
Intercompany loans receivable										(7,600,000)	(1,300,000)
Net cash (used in) provided by investing activities										(8,400,000)	(3,400,000)	(15,200,000)
Repayment of principal and redemption premium of 8.25% Senior Notes											0	0
Issuance of 5.875% Senior Notes											0
Repayment of Convertible Notes												0
Proceeds from cash-settled call options related to settlement of Convertible Notes												0
Payment for conversion premium related to settlement of Convertible Notes												0
Cash paid for debt issuance costs											0	0
Proceeds from stock option exercises											0
Repayment of capital lease										0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest												0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends and dividend equivalents paid										0	0	0
Cash dividends paid to Parent											0
Intercompany loans payable										0	(3,900,000)	12,800,000
Net cash (used in) provided by financing activities										0	(3,900,000)	12,800,000
Net decrease in cash, cash equivalents and restricted cash during the period										400,000	1,900,000	(2,100,000)
Cash, cash equivalents and restricted cash at beginning of period					$ 2,600,000				$ 700,000	2,600,000	700,000	2,800,000
Cash, cash equivalents and restricted cash at end of period		$ 3,000,000				$ 2,600,000				$ 3,000,000	$ 2,600,000	$ 700,000
Senior Notes | Senior Notes Due 2024
Condensed Financial Statements [Line Items]
Principal amount of notes														$ 375,000,000
Debt Instrument, Interest Rate, Stated Percentage														5.875%
Senior Notes | Senior Notes Due 2020
Condensed Financial Statements [Line Items]
Principal amount of notes																$ 225,000,000
Debt Instrument, Interest Rate, Stated Percentage																8.25%
Current liabilities:
Long-term debt													$ 197,800,000

[1] See Note 14 for supplemental disclosure on non-cash transactions.